|
Real-time Estimate
Cboe BZX
17:32:01 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 5.125 USD | +3.54% |
|
-37.70% | +27.89% |
| Market Cap | 74.17M 66.54M 61.52M 55.72M 104M 7.06B 105M 736M 293M 3.7B 278M 272M 11.73B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 72.9M 65.41M 60.47M 54.77M 102M 6.94B 104M 723M 288M 3.63B 274M 268M 11.53B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.75% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CPIX | Delayed | |
CBOE
| CPIX | Real-time |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | +3.84% | ||
| 1 week | -37.70% | ||
| Current month | -34.99% | ||
| 1 month | -34.07% | ||
| 3 months | -25.26% | ||
| 6 months | +18.93% | ||
| Current year | +27.89% |
| 1 week | 4.2 |  | 8.76 |
| 1 month | 4.2 | | 8.76 |
| Current year | 2.69 | | 9.28 |
| 1 year | 1.85 | | 9.28 |
| 3 years | 1.04 | | 9.28 |
| 5 years | 1.04 | | 9.28 |
| 10 years | 0 | | 9.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 06/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 16/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 06/01/1999 |
Gordon Bernard
BRD | Director/Board Member | 74 | 09/09/2010 |
James Jones
BRD | Director/Board Member | 78 | 31/12/2009 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 18/03/26 | Free | Director | 5,800 | 0.0388% | ||
| 18/03/26 | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.54% | -37.70% | +54.24% | +159.69% | 74.17M | |
| +0.42% | +1.34% | +57.02% | +127.63% | 1,143B | |
| +0.76% | +4.90% | +44.66% | +83.91% | 647B | |
| +0.38% | +0.90% | +26.29% | +102.53% | 506B | |
| -0.05% | +1.73% | +52.74% | +65.27% | 384B | |
| -0.94% | -6.08% | +61.74% | +37.09% | 350B | |
| +0.34% | +1.84% | +30.70% | +52.69% | 293B | |
| -0.45% | +1.19% | +2.89% | +24.92% | 265B | |
| +0.52% | +2.61% | +53.98% | +70.89% | 242B | |
| +0.37% | +3.75% | +35.16% | +104.87% | 197B | |
| Average | +0.53% | -3.02% | +41.94% | +82.95% | 402.76B | |
| Weighted average by Cap. | +0.26% | +0.71% | +44.45% | +86.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.98M 31.41M 28.45M 53.15M 3.61B 53.79M 376M 150M 1.89B 142M 139M 5.99B | 44.52M 39.94M 36.93M 33.45M 62.49M 4.24B 63.24M 442M 176M 2.22B 167M 164M 7.04B |
| Net income | -6.48M -5.81M -5.37M -4.87M -9.09M -617M -9.2M -64.26M -25.6M -323M -24.32M -23.8M -1.03B | -2.84M -2.54M -2.35M -2.13M -3.98M -270M -4.03M -28.13M -11.2M -141M -10.64M -10.42M -449M |
| Net Debt | 2.61M 2.34M 2.16M 1.96M 3.66M 248M 3.7M 25.87M 10.3M 130M 9.79M 9.58M 413M | -1.26M -1.13M -1.05M -950K -1.77M -120M -1.8M -12.54M -4.99M -63.01M -4.74M -4.64M -200M |
Employees
88
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | US$5.090 | +2.83% | 53,898 |
| 27/10/26 | US$4.950 | +13.79% | 542,992 |
| 26/10/26 | US$4.350 | -48.76% | 501,543 |
| 23/10/26 | US$8.490 | +0.12% | 44,315 |
| 22/10/26 | US$8.480 | +3.79% | 39,177 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
